???????????????????????FDA?
??FDA?12????????????????????????????????????????????????????Zileuton ??????????????????????????????????????????????????????
FDA Requests Labeling Change for Leukotriene Modifiers
??FDA Press Annoucement 2009.6.12?
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm166293.htm
Updated Information on Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)(????)
?Postmarket Drug Safety Information for Patients and Providers 2009.6.12 Update?
?FDA????????????? post-market reports ?????????????????????????????????????????????????????????????????FDA?????????????????????????????????????????????????????????????????????????????????
?FDA?????????????????????????????????
- ?????????????????????????????????????????????
- ???????????????????????????????
- ?????????????????????????????????????????
????????????????????????????2008?3?27??FDA?�Early Communication�?????????????????????????????????????????5???????????????????????????????????????????????????????????????????????????????????????????????????????
Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Montelukast (Singulair)???????2009.1.13?
???????????????????Vol.7 No.4??????????
?http://www.nihs.go.jp/dig/sireport/weekly7/04090219.pdf
??????????????Vol.6 No.9
?http://www.nihs.go.jp/dig/sireport/weekly6/09080502.pdf
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????
FDA says users of Singulair and similar meds should watch for such problems
?Health Day 2009.06.12?
?http://www.healthday.com/Article.asp?AID=628062